Literature DB >> 2784671

C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.

L C Antón1, J M Alcolea, P Sánchez-Corral, G Marqués, A Sánchez, F Vivanco.   

Abstract

Ovalbumin-antiovalbumin IgG immune aggregates were incubated with normal human serum in the presence of iodo[1-14C]acetamide, in conditions in which only the alternative pathway of complement was activated. The [14C]C3b-IgG covalent complexes formed were digested with pepsin, and analysed by SDS/polyacrylamide-gel electrophoresis and fluorography. Covalent complexes of [14C]C3-Fd and [14C]C3-pFc' were visualized, demonstrating that, during complement activation by the alternative pathway, C3 is covalently incorporated into the C gamma 3 domain of IgG, as well as into the Fd region. The C gamma 2 domain becomes protected from pepsin action by the bound C3b. All the covalent linkages between C3 and the IgG were sensitive to hydroxylamine. When [14C]C3-pFc' covalent complexes were treated with 1 M-NH2OH and loaded onto a Bio-Gel P-4 column, a radioactive peak of 3 kDa was obtained. The material released from [14C]C3-pFc' and [14C]C3-F(ab')2 complexes after treatment with 1 M-NH2OH was mixed and analysed in the Bio-Gel P-4 column. A similar radioactive peak of 3 kDa was obtained. When this peak, either from [14C]C3-pFc' alone or from the mixture of [14C]C3-F(ab')2 and [14C]C3-pFc', was fractionated by h.p.l.c., virtually the same radioactive peptide profile was obtained, indicating that very similar C3 peptides remained covalently bound to both regions (Fab and C gamma 3) of the antibody molecule. It is suggested that C3 bound to the C gamma 3 domain of IgG may interfere with the Fc-Fc interactions of immune aggregates and thus may be involved in several biological properties displayed by these complement-activating aggregates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784671      PMCID: PMC1135663          DOI: 10.1042/bj2570831

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  Mechanism of binding of soluble immune complexes to lymphocytes.

Authors:  A Eden; C Bianco
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.

Authors:  T Fujita; M Takiuchi; K Iida; K Nagaki; S Inai
Journal:  Immunochemistry       Date:  1977-01

6.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  Structural requirements of rabbit IgG F(ab')2 fragment for activation of the complement system through the alternative pathway--I. Disulfide bonds.

Authors:  J P Albar; C Juarez; F Vivanco-Martínez; R Bragado; F Ortíz
Journal:  Mol Immunol       Date:  1981-10       Impact factor: 4.407

8.  Purification and radiolabeling of human C1q.

Authors:  A J Tenner; P H Lesavre; N R Cooper
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

9.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

10.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  6 in total

Review 1.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

2.  Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system.

Authors:  L Persson; J Borén; A Nicoletti; G K Hansson; M Pekna
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36.

Authors:  S Albertí; G Marqués; S Hernández-Allés; X Rubires; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

Authors:  S Albertí; D Alvarez; S Merino; M T Casado; F Vivanco; J M Tomás; V J Benedí
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Authors:  S Albertí; G Marqués; S Camprubí; S Merino; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Activation of the complement classical pathway (C1q binding) by mesophilic Aeromonas hydrophila outer membrane protein.

Authors:  S Merino; M M Nogueras; A Aguilar; X Rubires; S Albertí; V J Benedí; J M Tomás
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.